Serum metabolic profiling enables diagnosis, prognosis, and monitoring for brainstem gliomas

Abstract Brainstem gliomas (BSG) is a highly malignant central nervous system childhood tumors with 5-year survival rate <10%. Metabolism during radiotherapy is a dynamic and precisely programmed process, improving clinical outcomes and guiding therapy decisions of BSG. Here we construct diagnost...

Full description

Saved in:
Bibliographic Details
Main Authors: Keke Li, Ruimin Wang, Zhengying Gu, Wenyun Weng, Wanshan Liu, Yida Huang, Jiao Wu, Ziyue Zhang, Shouzhi Yang, Jun Su, Yujie Tang, Kun Qian, Mawei Jiang, Lin Huang, Jingjing Wan
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-61163-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849769411218505728
author Keke Li
Ruimin Wang
Zhengying Gu
Wenyun Weng
Wanshan Liu
Yida Huang
Jiao Wu
Ziyue Zhang
Shouzhi Yang
Jun Su
Yujie Tang
Kun Qian
Mawei Jiang
Lin Huang
Jingjing Wan
author_facet Keke Li
Ruimin Wang
Zhengying Gu
Wenyun Weng
Wanshan Liu
Yida Huang
Jiao Wu
Ziyue Zhang
Shouzhi Yang
Jun Su
Yujie Tang
Kun Qian
Mawei Jiang
Lin Huang
Jingjing Wan
author_sort Keke Li
collection DOAJ
description Abstract Brainstem gliomas (BSG) is a highly malignant central nervous system childhood tumors with 5-year survival rate <10%. Metabolism during radiotherapy is a dynamic and precisely programmed process, improving clinical outcomes and guiding therapy decisions of BSG. Here we construct diagnostic and prognostic assays of BSG via circulating metabolites based on both cross-sectional study and longitudinal cohort study with 106 BSG patients. We employ nanoparticle enhanced laser desorption/ionization mass spectrometry to characterize static and dynamic snapshots of metabolites during BSG radiotherapy. We show that this serological tool reaches the area under the curve of 0.933 for BSG diagnosis in an independent blind test and predicts risk of patients with significant differences (p < 0.05) in prognostic outcomes. We further identify eight distinct temporal patterns of metabolite regulation associated with radiotherapy responses and tracked the metabolic trajectory via dynamic metabolic snapshots throughout radiotherapy process. If further validated, this framework could be extended to derive comprehensive metabolic pictures for cancers including but not limited to BSG.
format Article
id doaj-art-0c3285bc726e4929ae6b078bafaf90fa
institution DOAJ
issn 2041-1723
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-0c3285bc726e4929ae6b078bafaf90fa2025-08-20T03:03:25ZengNature PortfolioNature Communications2041-17232025-07-0116111510.1038/s41467-025-61163-9Serum metabolic profiling enables diagnosis, prognosis, and monitoring for brainstem gliomasKeke Li0Ruimin Wang1Zhengying Gu2Wenyun Weng3Wanshan Liu4Yida Huang5Jiao Wu6Ziyue Zhang7Shouzhi Yang8Jun Su9Yujie Tang10Kun Qian11Mawei Jiang12Lin Huang13Jingjing Wan14Department of Oncology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong UniversityState Key Laboratory of Systems Medicine for Cancer, School of Biomedical Engineering, Shanghai Jiao Tong UniversityDepartment of Clinical Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of MedicineKey Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Shanghai Key Laboratory of Reproductive Medicine, Department of Histoembryology, Genetics and Developmental Biology, Shanghai Jiao Tong University School of MedicineState Key Laboratory of Systems Medicine for Cancer, School of Biomedical Engineering, Shanghai Jiao Tong UniversityState Key Laboratory of Systems Medicine for Cancer, School of Biomedical Engineering, Shanghai Jiao Tong UniversityState Key Laboratory of Systems Medicine for Cancer, School of Biomedical Engineering, Shanghai Jiao Tong UniversityState Key Laboratory of Systems Medicine for Cancer, School of Biomedical Engineering, Shanghai Jiao Tong UniversityState Key Laboratory of Systems Medicine for Cancer, School of Biomedical Engineering, Shanghai Jiao Tong UniversityDepartment of Oncology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong UniversityKey Laboratory of Cell Differentiation and Apoptosis of National Ministry of Education, Shanghai Key Laboratory of Reproductive Medicine, Department of Histoembryology, Genetics and Developmental Biology, Shanghai Jiao Tong University School of MedicineState Key Laboratory of Systems Medicine for Cancer, School of Biomedical Engineering, Shanghai Jiao Tong UniversityDepartment of Oncology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong UniversityDepartment of Clinical Laboratory Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of MedicineSchool of Chemistry and Molecular Engineering, East China Normal UniversityAbstract Brainstem gliomas (BSG) is a highly malignant central nervous system childhood tumors with 5-year survival rate <10%. Metabolism during radiotherapy is a dynamic and precisely programmed process, improving clinical outcomes and guiding therapy decisions of BSG. Here we construct diagnostic and prognostic assays of BSG via circulating metabolites based on both cross-sectional study and longitudinal cohort study with 106 BSG patients. We employ nanoparticle enhanced laser desorption/ionization mass spectrometry to characterize static and dynamic snapshots of metabolites during BSG radiotherapy. We show that this serological tool reaches the area under the curve of 0.933 for BSG diagnosis in an independent blind test and predicts risk of patients with significant differences (p < 0.05) in prognostic outcomes. We further identify eight distinct temporal patterns of metabolite regulation associated with radiotherapy responses and tracked the metabolic trajectory via dynamic metabolic snapshots throughout radiotherapy process. If further validated, this framework could be extended to derive comprehensive metabolic pictures for cancers including but not limited to BSG.https://doi.org/10.1038/s41467-025-61163-9
spellingShingle Keke Li
Ruimin Wang
Zhengying Gu
Wenyun Weng
Wanshan Liu
Yida Huang
Jiao Wu
Ziyue Zhang
Shouzhi Yang
Jun Su
Yujie Tang
Kun Qian
Mawei Jiang
Lin Huang
Jingjing Wan
Serum metabolic profiling enables diagnosis, prognosis, and monitoring for brainstem gliomas
Nature Communications
title Serum metabolic profiling enables diagnosis, prognosis, and monitoring for brainstem gliomas
title_full Serum metabolic profiling enables diagnosis, prognosis, and monitoring for brainstem gliomas
title_fullStr Serum metabolic profiling enables diagnosis, prognosis, and monitoring for brainstem gliomas
title_full_unstemmed Serum metabolic profiling enables diagnosis, prognosis, and monitoring for brainstem gliomas
title_short Serum metabolic profiling enables diagnosis, prognosis, and monitoring for brainstem gliomas
title_sort serum metabolic profiling enables diagnosis prognosis and monitoring for brainstem gliomas
url https://doi.org/10.1038/s41467-025-61163-9
work_keys_str_mv AT kekeli serummetabolicprofilingenablesdiagnosisprognosisandmonitoringforbrainstemgliomas
AT ruiminwang serummetabolicprofilingenablesdiagnosisprognosisandmonitoringforbrainstemgliomas
AT zhengyinggu serummetabolicprofilingenablesdiagnosisprognosisandmonitoringforbrainstemgliomas
AT wenyunweng serummetabolicprofilingenablesdiagnosisprognosisandmonitoringforbrainstemgliomas
AT wanshanliu serummetabolicprofilingenablesdiagnosisprognosisandmonitoringforbrainstemgliomas
AT yidahuang serummetabolicprofilingenablesdiagnosisprognosisandmonitoringforbrainstemgliomas
AT jiaowu serummetabolicprofilingenablesdiagnosisprognosisandmonitoringforbrainstemgliomas
AT ziyuezhang serummetabolicprofilingenablesdiagnosisprognosisandmonitoringforbrainstemgliomas
AT shouzhiyang serummetabolicprofilingenablesdiagnosisprognosisandmonitoringforbrainstemgliomas
AT junsu serummetabolicprofilingenablesdiagnosisprognosisandmonitoringforbrainstemgliomas
AT yujietang serummetabolicprofilingenablesdiagnosisprognosisandmonitoringforbrainstemgliomas
AT kunqian serummetabolicprofilingenablesdiagnosisprognosisandmonitoringforbrainstemgliomas
AT maweijiang serummetabolicprofilingenablesdiagnosisprognosisandmonitoringforbrainstemgliomas
AT linhuang serummetabolicprofilingenablesdiagnosisprognosisandmonitoringforbrainstemgliomas
AT jingjingwan serummetabolicprofilingenablesdiagnosisprognosisandmonitoringforbrainstemgliomas